The Inhibitory Effect of HKa on Prostate Cancer Line DU145 Is Mediated by Blocking Metastasis
CSEF · 2008 Biochemistry/ Molecular Biology
Overview
Objectives/Goals Prostate Cancer is defined by the uncontrollable proliferation of prostate cells. When growth factors bind to their receptors, a transactivation signal is sent to EGFR and uPAR, resulting in clustering of EGFR and uPAR. This increases Cyclin D1 expression and facilitates migration of prostate cancer cells. High-molecular weight kininogen [HK] is a plasma protein responsible blood-clotting. Cleavage of HK results in the release of bradykinin and cleaved high molecular weight kininogen [HKa]. HKa induces apoptosis of proliferating epithelial cells and inhibits angiogenesis in vivo. The purpose of this experiment was to prevent the metastasis of prostate cancer cells through implementation of HKa. HKa would bind to uPAR and prevent the transactivation signaling from growth factors to EGFR. This competitive inhibition would inhibit metastasis of prostate cancer cells. Methods/Materials Sub-cultured Prostate Caner DU145 cells into six 35mm2 dishes coated with 1mL Collagen [10¥ìg/mL] until monolayer is formed. Measured metastasis/migration of Prostate Cancer DU145 cells in vitro through a Migration Assay. 3 dishes were Control. 3 dishes were HKa Treated. Added 6.09¥ìL HKa [100nM] to HKa Treated dishes. Added 2mL Pure Media [DMEM + L-Glut] with Zn2+ [15¥ìM] and 2¥ìL bFGF [20ng/mL] to each dish. Incubated each dish at 37¢ªC for 24 hours. After incubation, fixed tumor cells with 2mL Formalin Solution [1.2mL DPBS Buffer + 0.8mL 10% Formaldehyde] and incubated at 4¢ªC. Pictures of each migration line were taken at 0 and 24 hours to show contrast/growth of cells in the Control and HKa Treated dishes. Results EGFR and uPAR co-localized on the surface of Prostate Cancer DU145 cells in response to bFGF [20ng/ml]. Immunofluorescence microscopy showed that HKa disrupted co-localization of EGFR and uPAR, indicating that HKa prevented transactivation signaling from growth factors to EGFR. HKa inhibited migration of DU145 cells at 24 hours by the Migration Assay. A monoclonal antibody against uPAR also blocked migration of DU145 cells at 24 hours by the Migration Assay. It suggested that HKa inhibited migration of tumor cells by targeting uPAR. Conclusions/Discussion HKa disrupted the interaction of EGFR and uPAR and inhibited migration of Prostate Cancer DU145 cells across migration line. It indicates that HKa might prevent metastasis of human Prostate Cancer.
Summary statement
My project investigates the use of cleaved high molecular-weight kininogen, a plasma protein, in inhibiting the metastasis of Prostate Cancer Cell Line DU145 in vitro.
Help received
Participant in Physician Scientist Training Program; gained mentorship/workspace from faculty at Sol Sherry Thrombosis Research Center at Temple University School of Medicine in Philadelphia, PA.
Competition history
- CSEF 2008
Resources
Related projects
CSEF · 2009
Further Investigation of the Inhibitory Effect of HKa on Metastasis of Prostate Cancer Cell Line DU145
JSHS · 2025
Targeting RAGE: A Novel Therapeutic Strategy Against AGE-Mediated Prostate Cancer Progression
AJAS · 2026
Targeting RAGE: A Novel Therapeutic Strategy Against AGE-Mediated PCa Progression
ISEF · 2017
Inhibition of Bone Metastasis in MDA-MB-231 and PC-3 Cells by the Extracellular Adherence Protein of Staphylococcus aureus
ISEF · 2025
Assessing Novel RIPK2-MKK7 Interaction Inhibitors in Prostate Cancer Cell Lines
ISEF · 2018
Inhibitor A: Targeting Therapeutically Resistant HER2+ Breast Cancer Tissues
CSEF · 2019
Anacardic Acid Analogs as Inhibitors of Matrix Metalloproteinase-2 for the Prevention of Cancer Metastasis
CSEF · 2011
Regulation of Fibronectin Expression by EGR1 in Prostate Cancer Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects